SRD5A2 and benign prostatic hyperplasia: Overexpression of SRD5A2 (p < 0.001) (Figure 2B), AR (p < 0.001) (Figure 2C), and PSA (p < 0.001) (Figure 2D) in BPH-1 cells was downregulated by SIN treatment (Figure 2A).